Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS)

NCT07706855 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

ARDS (Acute Respiratory Distress Syndrome)

Interventions

DRUG: GKL-006RTU injection
DRUG: Placebo

Sponsor

Beijing Gene Key Life Technology Co., Ltd